• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以梗阻性尿病和急性肾损伤为表现的进展性多发性硬化症:一例报告

Progressive Multiple Sclerosis Presenting With Obstructive Uropathy and Acute Kidney Injury: A Case Report.

作者信息

Jamil Ahmed, Banerjee Anup, Suham Amin, Habib Nosheen

机构信息

Acute Medicine, Stepping Hill Hospital, Stockport NHS Foundation Trust, Stockport, GBR.

出版信息

Cureus. 2025 Aug 8;17(8):e89643. doi: 10.7759/cureus.89643. eCollection 2025 Aug.

DOI:10.7759/cureus.89643
PMID:40787189
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12334146/
Abstract

Very-late-onset multiple sclerosis (VLOMS), defined as disease onset after the age of 60, is a rare and often diagnostically challenging entity that may present with atypical features. We describe the case of a 67-year-old man who presented with progressive urinary symptoms culminating in obstructive uropathy and acute kidney injury (AKI), ultimately diagnosed as progressive multiple sclerosis (MS). The patient had a three-year history of left upper limb weakness and gait difficulty, which had been previously unexplored. He presented acutely following a fall, with new-onset left-sided facial droop and worsening lower limb weakness. Laboratory investigations revealed severe hyperkalemia (serum potassium: 9.8 mmol/L), uremia, and elevated creatinine (731 µmol/L), indicating significant renal impairment (estimated glomerular filtration rate (eGFR): 7 mL/min/1.73 m²). Urinary tract imaging revealed bilateral hydronephrosis and a trabeculated bladder, suggestive of chronic urinary retention; the prostate was enlarged but without significant prostate-specific antigen (PSA) elevation. Catheterization led to immediate bladder decompression, and the patient received medical treatment for hyperkalemia. Neuroimaging (MRI brain and spine) revealed multifocal demyelinating lesions involving periventricular, temporal, pontine, and cervical cord regions, while a lumbar puncture confirmed the presence of oligoclonal bands in both CSF and serum. Neurological examination demonstrated upper motor neuron signs, including facial asymmetry, limb spasticity, and pyramidal weakness, further supporting a central nervous system etiology. Despite the presence of benign prostatic hyperplasia (BPH) and cervical spondylosis, the degree of neurological impairment, distribution of MRI lesions, and cerebrospinal fluid analysis collectively pointed to a diagnosis of progressive MS with neurogenic bladder dysfunction. This led to urinary retention, obstructive uropathy, and subsequent AKI. While lower urinary tract dysfunction is a common complication of MS, its initial manifestation as acute renal failure is rare, especially in patients without a prior diagnosis. This case highlights the diagnostic complexity in elderly patients where structural (BPH, spinal stenosis) and neurological causes may overlap. It also underscores the importance of a high index of suspicion for demyelinating disease in patients with unexplained bladder dysfunction, progressive motor deficits, and renal impairment. Early multidisciplinary involvement, including neurology, urology, nephrology, and rehabilitation, is essential for prompt diagnosis, bladder decompression, and prevention of irreversible renal damage. Long-term catheterization was instituted, with outpatient follow-up arranged to assess suitability for clean intermittent self-catheterization and continued neurological monitoring. This case illustrates that in older adults, especially men, attributing urinary symptoms solely to common urological conditions may overlook more insidious neurologic diseases such as MS. Timely recognition and appropriate intervention can significantly alter prognosis by preserving renal function and optimizing functional outcomes.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/681b/12334146/b57448116749/cureus-0017-00000089643-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/681b/12334146/da822c7fb075/cureus-0017-00000089643-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/681b/12334146/91677f69921d/cureus-0017-00000089643-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/681b/12334146/b57448116749/cureus-0017-00000089643-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/681b/12334146/da822c7fb075/cureus-0017-00000089643-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/681b/12334146/91677f69921d/cureus-0017-00000089643-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/681b/12334146/b57448116749/cureus-0017-00000089643-i03.jpg
摘要

迟发性多发性硬化症(VLOMS)定义为60岁以后发病,是一种罕见且诊断颇具挑战的疾病,可能具有非典型特征。我们描述了一名67岁男性的病例,他出现进行性泌尿系统症状,最终发展为梗阻性肾病和急性肾损伤(AKI),最终被诊断为进行性多发性硬化症(MS)。该患者有三年的左上肢无力和步态困难病史,此前未得到诊断。他在一次跌倒后急性发病,出现新发左侧面部下垂和下肢无力加重。实验室检查显示严重高钾血症(血清钾:9.8 mmol/L)、尿毒症和肌酐升高(731 µmol/L),提示严重肾功能损害(估计肾小球滤过率(eGFR):7 mL/min/1.73 m²)。泌尿系统影像学检查显示双侧肾积水和膀胱小梁化,提示慢性尿潴留;前列腺肿大,但前列腺特异性抗原(PSA)无明显升高。导尿后膀胱立即减压,患者接受了高钾血症的药物治疗。神经影像学检查(脑部和脊柱MRI)显示多灶性脱髓鞘病变,累及脑室周围、颞叶、脑桥和颈髓区域,而腰椎穿刺证实脑脊液和血清中均存在寡克隆带。神经系统检查显示上运动神经元体征,包括面部不对称、肢体痉挛和锥体束征,进一步支持中枢神经系统病因。尽管存在良性前列腺增生(BPH)和颈椎病,但神经功能损害程度、MRI病变分布和脑脊液分析共同指向诊断为伴有神经源性膀胱功能障碍的进行性MS。这导致了尿潴留、梗阻性肾病及随后的AKI。虽然下尿路功能障碍是MS的常见并发症,但其最初表现为急性肾衰竭却很罕见,尤其是在未预先诊断的患者中。该病例凸显了老年患者诊断的复杂性,其中结构性(BPH、椎管狭窄)和神经学原因可能重叠。它还强调了对于不明原因膀胱功能障碍、进行性运动功能缺损和肾功能损害患者,高度怀疑脱髓鞘疾病的重要性。早期多学科参与,包括神经科、泌尿科、肾内科和康复科,对于及时诊断、膀胱减压和预防不可逆肾损伤至关重要。已开始长期导尿,并安排门诊随访以评估清洁间歇性自我导尿的适用性和持续的神经学监测。该病例表明,在老年人,尤其是男性中,仅将泌尿系统症状归因于常见泌尿系统疾病可能会忽略更隐匿的神经系统疾病,如MS。及时识别和适当干预可通过保护肾功能和优化功能结局显著改变预后。

相似文献

1
Progressive Multiple Sclerosis Presenting With Obstructive Uropathy and Acute Kidney Injury: A Case Report.以梗阻性尿病和急性肾损伤为表现的进展性多发性硬化症:一例报告
Cureus. 2025 Aug 8;17(8):e89643. doi: 10.7759/cureus.89643. eCollection 2025 Aug.
2
Uncommon Non-MS Demyelinating Disorders of the Central Nervous System.中枢神经系统罕见的非多发性硬化脱髓鞘疾病
Curr Neurol Neurosci Rep. 2025 Jul 1;25(1):45. doi: 10.1007/s11910-025-01432-8.
3
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
4
Azathioprine for people with multiple sclerosis.硫唑嘌呤用于多发性硬化症患者。
Cochrane Database Syst Rev. 2024 Dec 9;12(12):CD015005. doi: 10.1002/14651858.CD015005.pub2.
5
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
6
Systemic Inflammatory Response Syndrome全身炎症反应综合征
7
Severe Relapsing Hailey-Hailey Disease Displaying a Durable Complete Response to Hydroxyurea.严重复发性黑利-黑利病对羟基脲呈现持久完全缓解
Acta Dermatovenerol Croat. 2024 Nov;32(3):168-169.
8
-Related Overgrowth Spectrum相关过度生长谱系
9
Siponimod for multiple sclerosis.西尼莫德用于多发性硬化症。
Cochrane Database Syst Rev. 2021 Nov 16;11(11):CD013647. doi: 10.1002/14651858.CD013647.pub2.
10
Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction.成年神经源性膀胱功能障碍患者功能性膀胱出口梗阻的外科治疗
Cochrane Database Syst Rev. 2014 May 24;2014(5):CD004927. doi: 10.1002/14651858.CD004927.pub4.

本文引用的文献

1
Renal disease associated with multiple sclerosis: A narrative review.多发性硬化相关肾脏疾病:一篇叙述性综述。
Medicine (Baltimore). 2024 May 17;103(20):e38222. doi: 10.1097/MD.0000000000038222.
2
Clinical and radiologic differences between early onset, late onset, and very late onset adult multiple sclerosis.成人早发性、晚发性和极晚发性多发性硬化的临床和影像学差异。
Mult Scler Relat Disord. 2023 Dec;80:105132. doi: 10.1016/j.msard.2023.105132. Epub 2023 Nov 7.
3
The age at onset of relapsing-remitting multiple sclerosis has increased over the last five decades.
在过去的五十年里,复发缓解型多发性硬化症的发病年龄有所增加。
Mult Scler Relat Disord. 2022 Dec;68:104103. doi: 10.1016/j.msard.2022.104103. Epub 2022 Aug 9.
4
Clinical Features of Late-Onset Multiple Sclerosis: a Systematic Review and Meta-analysis.迟发性多发性硬化症的临床特征:系统评价和荟萃分析。
Mult Scler Relat Disord. 2021 May;50:102816. doi: 10.1016/j.msard.2021.102816. Epub 2021 Feb 4.
5
A Review of Botulinum Toxin A for the Treatment of Neurogenic Bladder.用于治疗神经源性膀胱的A型肉毒毒素综述
PM R. 2019 Feb;11(2):192-200. doi: 10.1016/j.pmrj.2018.07.016. Epub 2019 Feb 13.
6
Lower urinary tract dysfunction in the neurological patient: clinical assessment and management.神经系统疾病患者的下尿路功能障碍:临床评估与管理。
Lancet Neurol. 2015 Jul;14(7):720-32. doi: 10.1016/S1474-4422(15)00070-8.
7
EAU guidelines on neurogenic lower urinary tract dysfunction.EAU 指南:神经原性下尿路功能障碍
Eur Urol. 2009 Jul;56(1):81-8. doi: 10.1016/j.eururo.2009.04.028. Epub 2009 Apr 21.
8
The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines.多发性硬化症中的神经源性膀胱:文献综述及管理指南建议
Mult Scler. 2007 Aug;13(7):915-28. doi: 10.1177/1352458506075651. Epub 2007 Mar 15.
9
Neurogenic bladder in patients with cervical compressive myelopathy.颈椎压迫性脊髓病患者的神经源性膀胱
J Spinal Disord Tech. 2005 Aug;18(4):315-20. doi: 10.1097/01.bsd.0000166638.31398.14.
10
Bladder, bowel and sexual dysfunction in multiple sclerosis: management strategies.多发性硬化症中的膀胱、肠道及性功能障碍:管理策略
Drugs. 2003;63(2):153-66. doi: 10.2165/00003495-200363020-00003.